Navigation Links
Forsyth scientists find three bacteria associated with oral cancer

ists compared bacterial samples from the saliva of 229 healthy subjects with samples from 45 patients who had been diagnosed with oral cancer. The team found elevated levels of three bacterial species (C. gingivalis, P. melaninogenica and S. mitis) in oral cancer patients. The scientists obtained similar findings when they controlled for gender, age, and smoking history.

According to Mager, "Those results led us to hypothesize that the three species could serve as diagnostic indicators for OSCC. And, in fact, we found that elevated salivary counts of the three bacteria correctly identified 80% of individuals with oral cancer and 83% of controls."

If their findings are replicated in future studies, the Forsyth team envisions a simple saliva test that could be administered by dental technicians in large screenings, mailed to a diagnostic center, and returned to doctors or dentists within several days.

The need for screening
Government statistics show that, every year, some 30 thousand US residents are diagnosed with oral cancer. Of those diagnosed, more than 90 per cent are found to have OSCC. If discovered and treated early, OSCC has a five-year survival rate of 80-to-90 percent. But 60 percent of OSCC cases are not diagnosed until the later stages and fewer than 54 per cent of individuals diagnosed in those stages live for five years¡Xplacing OSCC among the deadliest of cancers.

"Far too many people are not diagnosed until their oral cancer is in its advanced stages," Mager said. In part, that is because, in its early stages, oral cancer may be asymptomatic or mimic benign conditions, so those who have it do not seek dental or medical care. "A saliva test would be an easy, non-invasive way to diagnose or monitor patients."

Until such a test exists, Mager added, "I cannot overemphasize how important it is for every adult to be examined by a dental or medical health professional for signs of oral cancer at least once a yea
'"/>

Source:The Forsyth Institute


Page: 1 2 3

Related biology news :

1. New understanding of regeneration gained by Forsyth scientists
2. Forsyth scientists gain greater understanding of how embryos differentiate left from right
3. Wisconsin scientists grow critical nerve cells
4. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
5. UAB scientists discover the origin of a mysterious physical force
6. Fox Chase Cancer Center scientists identify immune-system mutation
7. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
8. U-M scientists find genes that control growth of common skin cancer
9. UCLA scientists transform HIV into cancer-seeking missile
10. RNA project to create language for scientists worldwide
11. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals

Post Your Comments:
(Date:11/24/2009)... Spanish . , The presence of increased body ...ubstances in the blood, hinders the loss and maint...ect of the University of Navarra conducted by Estb... Pharmacy. , The project, entitled "A nutrigenet...ol of body weight and inflammation," examines how ...
(Date:11/23/2009)... The time of day matters to forest trees dealing w...a research team led by Professor Malcolm Campbell,...l for research and colleagues in the department of.... , Capitalizing on their previous work to dec...am examined how poplar trees use their 45,000 gene...
(Date:11/23/2009)... provides "incontrovertible evidence" that the vol...tra about 73,000 years ago deforested much of cent...searchers report. , The volcano ejected an estim...re, leaving a crater (now the world,s largest volc...meters wide. Ash from the event has been found in ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Hard To Treat Diseases 28HTDS PK 29 Thailand Registration 52304 1Hard To Treat Diseases 28HTDS PK 29 Thailand Registration 52304 2Columbia leads national effort to develop early intervention for schizophrenia 52300 1Columbia leads national effort to develop early intervention for schizophrenia 52300 2Columbia leads national effort to develop early intervention for schizophrenia 52300 3 242 million grant aids study of lung cancer in people who never smoked 9305 1 242 million grant aids study of lung cancer in people who never smoked 9305 2 242 million grant aids study of lung cancer in people who never smoked 9305 3
... , The largest living structures on Earth and the...e at risk, the most definitive review yet of the i...s concluded. , In a paper published in the presti...ientists reveal that world leaders face a race aga... communities dependent upon them for the inevitabl...
...-- A pioneering study of wild chimpanzees has foun...y experience menopause, rebutting previous studies...female chimpanzees reach reproductive senescence a...ata from wild gorillas and orangutans, the finding...logy -- suggests that human females are rare or ev...
...searchers from the University of Pennsylvania and ...ason why one of the most commonly activated protei...re Genetics this week, the Myc protein can stop th...s of nucleic acid that help control which genes ar...tances, re-introducing repressed miRNAs ,into Myc-...
Other Biology News:It's official: The carbon crisis is lethal for coral reefs 2It's official: The carbon crisis is lethal for coral reefs 3It's official: The carbon crisis is lethal for coral reefs 4Wild chimpanzees appear not to regularly experience menopause 2University of Pennsylvania researchers zero in on the tiniest members in the war on cancer 2
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq...ingandcommercializingnovelpainmanagementtherapies,...ExecutiveOfficer,isscheduledtopresentatthe21stAnnu...r1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork....lOfficer,willbeavailabletorespondtoquestionsduring...
(Date:11/24/2009)...Newswire/--BlueMarbleEnergyCorp.announcedtodaythat...PDA)wererecentlyawarded$2millionbyWashingtonState,...ate/publicpartnershiptoconstructthestate,sfirstspe..., "Thisinvestmentwillsignificantlyspeedthedevelo...olnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."We...
(Date:11/24/2009)...dpointhasbeenmetforpatientswithadvanced-stage,orre.../PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ:...icalcompanyfocusedonendocrinetherapyandoncology,to...thitstargetedcytotoxicpeptideconjugate,AEZS-108(fo...ometrialcancer.Inapersonalizedhealthcareapproach,t...
(Date:11/24/2009).../PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: ...,today,announcedthatithassubmittedaMAAtotheEuropea...enzymereplacementtherapyindevelopment,forthetreatm...pplicationforvelaglucerasealfathathasbeensubmitted...a. , Basedonaglobalsupplyshortageofthecurrent...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...Nov. 12 AMDL, Inc. (Amex:,ADL), a vertically inte...hina and the US, announced today preliminary third...ation., For the third quarter of FY2008, AMDL exp... and net sales after sales promotions of,approxima...approximately,$4.9 million and income from operati...
...Nov. 12 Novavax, Inc.,(Nasdaq: NVAX ) a clinical...ahul Singhvi, President and Chief Executive Office...s 5th Annual Healthcare Conference at 3:00 pm.,(ES...w York city. Dr.,Singhvi will provide an overview ...t progress. A link to the live presentation can be...
...alia, Nov. 12 Phosphagenics,Limited ("Phosphagenic...it,has initiated a phase 1 human clinical trial us...e targeted delivery of a leading non steroidal,ant... will compare the,bioavailability and penetration ...fenac), one of the leading marketed products, and ...
Other Biology Technology:AMDL Announces Preliminary Third Quarter Earnings; Revises 2008 Guidance 2AMDL Announces Preliminary Third Quarter Earnings; Revises 2008 Guidance 3Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans 2
Nuclear / Cytosol Fractionation Kit from MBL International
Cytosol / Particulate Rapid Separation Kit from MBL International
Starter Accessory Package I from Bethyl Laboratories
Mouse Anti-Human CD182 (CXCR2) Monoclonal Antibody, Unconjugated, Clone 5E8/CXCR2 from BioLegend
Biology Products: